National Institute on Drug Abuse
Division of Treatment Research and Development
Clinical/Medical Branch
Branch Functions
- To plan, design, and implement a comprehensive program that evaluates investigational and marketed medications for their potential value in treating substance abuse disorders.
- To file, as appropriate, Investigational New Drug (IND) applications for clinical projects in conjunction with the Regulatory Affairs Branch.
- To design, conduct, and monitor clinical trials for safety and efficacy of new and currently marketed medications in the treatment of substance abuse disorders.
- To provide consultation and advice on study design and analysis issues involved in clinical trials. To provide consultation on design and analysis issues for clinical indications. To analyze clinical data for medications development projects, using established methodologies as appropriate and developing new analysis methods when current methods are judged inappropriate.
- To provide consultation and collaboration with the pharmaceutical industry, academia, and other interested parties regarding projects of mutual interest.
- To support research training of clinicians to increase the skills, quantity, quality, and utilization of research in medications development.
|
|